Lifecore Expands its Aseptic Production of Pharmaceutical Drugs CHASKA, Minn., May 17, 2021 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc., a fully-owned subsidiary of LandecRead More…
Landec’s Lifecore Invests in CDMO Capabilities to Support Expansion into New Drug Applications
Landec Raises Fiscal Year 2017 Capital Spend Guidance from $25 million to approximately $30 million MENLO PARK, Calif., Oct. 12,Read More…